Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 24 radiotherapy PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


radiotherapy PhD Projects, Programmes & Scholarships

We have 24 radiotherapy PhD Projects, Programmes & Scholarships

FLASH VHEE Radiotherapy Machine System Design

A studentship is available from October 2024 on the development of a unique machine to deliver FLASH radiotherapy. To achieve this goal we anticipate strong collaboration with STFC’s Daresbury Laboratory and CERN. Read more

Designing and evaluating novel nanotherapeutics to enhance the effectiveness of radiotherapy in the treatment of solid cancers.

One in two cancer patients will receive radiotherapy as part of their treatment. For patients with a localised cancer diagnosis effective radiotherapy represents the best chance of a curative outcome, however, is not without risk. Read more

Graduate Teaching Assistant PhD Scholarships in Health and Social Care

Sheffield Hallam University is excited to announce Graduate Teaching Assistant (GTA) PHD scholarship opportunities in Health and Social care, starting 01 October 2024. Read more

(MRC DTP CASE) Understanding how tumour associated macrophages control the tumour immune landscape in NF2-Schwannomatosis

Type 2 Neurofibromatosis (NF2), now referred to as NF2-Schwannomatosis (or NF2-SWN), is a rare autosomal dominant tumour pre-disposition syndrome characterised by growth of typically benign tumours throughout the nervous system. Read more
Last chance to apply

Optical fiber-based RF-breakdown detection and prediction

The QUASAR Group, based at the Cockcroft Institute, in collaboration with the beam instrumentation company D-Beam Ltd, have pioneered the development and commercialization of optical fiber-based beam loss monitors for particle accelerators. Read more

Investigating local invasion in primary and secondary brain tumours

Brain tumours are highly invasive and carry a poor prognosis. Secondary brain tumours or brain metastases (BM) are the most common tumours found in the brain affecting up to one third of patients with solid organ cancer. Read more
Last chance to apply

Cardiotoxicity of Anticancer Drugs

Faculty of Pharmacy, Charles University, Department of Biochemical Sciences. The project fits into the field of cardio-oncology, which deals with the detection, prevention and treatment of cardiovascular diseases that occur as a side effect of chemotherapy and radiotherapy. Read more

Preclinical testing of collagen synthesis inhibitors for fibrotic disease

Fibrotic disease is characterised by an excessive accumulation of collagen within tissues, which then impedes tissue function. Organ fibrosis specifically kidney fibrosis, liver fibrosis, cardiac fibrosis and lung fibrosis have limited treatment options, pose a huge clinical burden and are life-limiting diseases. Read more

A Hybrid Plasma Accelerator for Therapeutic Electron Beams

Would you like to join us at the University of Manchester to change the future of particle accelerators?. Using the available studentship, you will explore combining mature electron production technology with new plasma-based acceleration. Read more

Identifying DNA methylation signatures of prostate cancer progression and mortality among patients with clinically confirmed, localised disease at baseline in a large prospective clinical trial

Rationale. Prostate Cancer (PCa) is a leading cause of male mortality, with 336,000 deaths worldwide each year (1). Although most PCa cases are indolent, slow-growing, and tend not to progress, a subset of PCa cases are more aggressive and will progress to metastases, treatment resistance and death. Read more

Transcriptome biomarkers and mechanisms of chemoresistance

Project Summary. This project aims to identify biomarkers linked to the most potent multimodal anticancer therapy with the least toxicity to counteract hemoresistance in head and neck squamous cell carcinoma (HNSCC). Read more

Discovery of Novel Cancer Immunotherapeutic Agents

Summary. Although cancer therapeutics, mainly chemotherapy and radiotherapy, have been extremely useful in the treatment of cancer, this disease is still associated with high morbidity and mortality. Read more

3D & 4D PRINTING IN CANCER MANAGEMENT

According to WHO, cancer is the second leading cause of death worldwide, with nearly 1 in 6 deaths been due to cancer. The principal modes of cancer management are surgery, radiotherapy, chemotherapy and pharmaceutical agents. Read more
  • 1

Filtering Results